Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 May 1;141(5):e41.
doi: 10.1093/brain/awy061.

Reply: Noisy but not placebo: defining metrics for effects of neurofeedback

Affiliations
Comment

Reply: Noisy but not placebo: defining metrics for effects of neurofeedback

Manuel Schabus. Brain. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cortese S, Ferrin M, Brandeis D, Holtmann M, Aggensteiner P, Daley D, et al.Neurofeedback for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry 2016; 55: 444–55. - PubMed
    1. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008; 59: 565–90. - PubMed
    1. Schabus M. Reply: On assessing neurofeedback effects: should double-blind replace neurophysiological mechanisms? Brain 2017; 140: e64. - PMC - PubMed
    1. Schabus M, Griessenberger H, Gnjezda MT, Heib DPJ, Wislowska M, Hoedlmoser K. Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia. Brain 2017; 140: 1041–52. - PMC - PubMed
    1. Schedlowski M, Enck P, Rief W, Bingel U. Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice. Pharmacol Rev 2015; 67: 697–730. - PubMed

MeSH terms